Nautilus Biotechnolgy
NAUT
NAUT
69 hedge funds and large institutions have $43.3M invested in Nautilus Biotechnolgy in 2025 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 18 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
69
Holders Change
-18
Holders Change %
-20.69%
% of All Funds
0.93%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
11
Increased
24
Reduced
18
Closed
28
Calls
$115K
Puts
–
Net Calls
+$115K
Net Calls Change
+$95K
Top Buyers
| 1 |
Millennium Management
New York
|
+$701K |
| 2 |
Corient Private Wealth
Miami,
Florida
|
+$283K |
| 3 |
Renaissance Technologies
New York
|
+$232K |
| 4 |
YIH
Y-Intercept (HK)
Hong Kong
|
+$163K |
| 5 |
Jane Street
New York
|
+$158K |
Top Sellers
| 1 |
BlackRock
New York
|
-$1.57M |
| 2 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
-$923K |
| 3 |
State Street
Boston,
Massachusetts
|
-$529K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$433K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$248K |
